University of Alabama

Clinical research site in South Birmingham, Alabama

As of July 2026, 1 paid clinical trial is recruiting at University of Alabama in South Birmingham, Alabama. Active studies at this site cover conditions such as Pediatric Sarcoma, Refractory and Pediatric Sarcoma, Relapsed. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at University of Alabama (1)

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

for Pediatric Sarcoma, Refractory

22 locations incl. South Birmingham

Sponsor: Nationwide Children's Hospital

Sex: All·Age: 2 - 40

Code: NCT05634369·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

More research sites in South Birmingham

The University of Alabama at Birmingham (1 trial)

Explore more

Paid clinical trials in South Birmingham, AL · Alabama clinical trials